. Summary for Patients: Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide. Ann Intern Med 2025 Apr 4. doi: 10.7326/ANNALS-24-03849.
PMID: 40340500